NEW YORK (GenomeWeb News) — PerkinElmer said yesterday that its board of directors has declared a quarterly dividend and, as expected, has elected President and COO Robert Friel to the post of CEO.
 
The company said the quarterly dividend of $.07 per share of common stock is payable on May 9 to all shareholders of record by the close of business on April 18.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.